Change in bowel or bladder habits .
A sore that does not heal. Unusual bleeding or discharge. Thickening or lump in breast or elsewhere . Indigestion or difficulty in swallowmg. Obvious change in wart or mole . Nagging cough or hoarseness.
These are potential signs of cancer with which the occupational health nurse (OHN) is well acquainted . The OHN assesses patients in the workplace on a regular basis and directs them to see their physicians for medical care when they exhibit any of the seven warning signals. This special issue will help the OHN to guide the newly diagnosed patient in the right direction for state-of-the-art care instead of seeking quacks . It is important to remember that morbidity and mortality of several cancers can be greatly reduced by early detection and appropriate treatment. This issue will address scientific methods of cancer care and as well as common unscientific (unproven) methods.
Prospects for specific cancer cures are encouraging . The FQA has recently approved the use of Alpha Interferon to treat hairy cell leukemia . Investigational protocols , using various biological response modifiers to effect a cure, are becoming more common. The use of Interferon, Interleukin-2, Tumor Necrosis Factor and Monoclonal Antibodies in cancer care are addressed in this issue . It is hoped that these new therapies will enable the cancer patient to live longer, more comfortably, and more productively. The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program asserts that 48% of all patients with cancer can now be cured. With increased efforts to scientifically examine the effects of drugs, singly and in combinations, as is currently being done with various chemotherapy agents, the prospects for specific cancer cures are improving.
Nurses in many settings are being asked to participate in clinical research involving the use of biological response modifiers . It behooves the nurse in the occupational health setting to learn about the sideeffects of these agents because most of the patients receiving these investigational agents have high performance status and do return to the workplace between their treatments . The s ide -effects of Interleukin-2, Interferon, Tumor Necrosis Factor and Monoclonal Antibodies are discussed in this issue . Nursing assessments, interventions and evaluations related to dysfunctions of the cardiopulmonary, gastrointestinal and urinary systems are listed as well as ways to assist patients in dealing with fatigue. The important topic of emotional support for patients receiving treatment through investigational research is also addressed.
Nausea and vomiting associated with chemotherapy can be minimized by appropriate use of antinauseants . Since most cancer patients today spend almost all of their time away from hospitals and only come to the hospital intermittently for treatment , an article on the use of antinauseants acquaints the occupational health nurse with new effective ways of dealing with the problem of nausea and vomiting.
Administering cancer drugs and analgesics by new drug delivery systems has created a need for the nurse to become skilled in caring for patients who go home with Hickrnan'" Catheters , implantable portsInfusaid'" and Jnfusor'" pumps. Patient education for patients with these devices and their families should be continued at the workplace. It is important that the occupational health nurse be able to provide information and answer questions about these devices when necessary.
The annual death toll from malignancy in the U.S. is at least 450,000 and cancer ranks second as the leading cause of death in the U.S. Though we are seeing people live longer with a diagnosis of cancer and more cancers are being cured, this issue would not be complete without a discussion of state of the art hospice care . More terminally ill cancer patients are asking to experience death without having to be bothered with catheters, oxygen, or intravenous fluid support . Patients today who elect to die at home or who refuse extraordinary measures to keep them alive in the hospital can die with the support of health professionals employed by hospice programs . Please read the article in this issue which describes state of the art hospice care.
There will be 870,000 new cancer cases diagnosed this year. Due to this it becomes necessary to recommend measures which are likely to reduce cancer risk. The American Cancer Society, the National Research Council of the National Academy of Sciences and the National Cancer Institute have approved several nutritional guidelines. Occupational health nurses can advise employees to:
• Consume only moderate amounts of salt-cured, smoked or nitritecured foods.
• Drink alcoholic beverages in moderation .
• Eat cruciferous vegetables, such as cauliflower, broccoli , brussels sprouts , kohlrabi, and cabbage.
• Include more high-fiber foods in your diet. These include whole grain cereals, fruits and vegetables .
• Use foods rich in Vitamin A and C in the daily diet.
• Avoid obesity.
• Cut down on total fat intake .
Another way to reduce cancer risk is to stop smoking. Smoking causes lung cancer. The number of persons who smoke cigarettes or use other nicotine products is decreasing , but the death rate from lung cancer continues to increase, according to the Epidemiology and Statistics Department of the American Cancer Society, August 1984.
Directing patients to take preventive measures, go to appropriate treatment centers when warning signs of cancer present themsel ves, and supporting patients receiving treatments while maintaining their jobs are major roles for the occupational health nurse . It is my hope that this issue will supply information to enhance the occupational health nurse' 
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